RxDoctor Payments DataLook up a doctor →

SCEMBLIX: payments to doctors

Payments that named SCEMBLIX as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.8M
Providers
8,838
Transactions
35,156
Average per transaction
$51

The per-transaction average — $51 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,838 providers the average total is $202, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis$1,682,82894.2%
Novartis Pharma AG$103,9505.8%
← All drugs & devices